This federal contract award is for the delivery of 100 capsules of the prescription drug Vyvanse (70 mg) to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024, with a ceiling value of $2,162.01 and an ultimate completion date of December 3, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition.
AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 3/9/25, 12:43 AM